| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.73B | -12.0% |
| Cost of Revenue | $550.2M | -10.1% |
| Gross Profit | $1.18B | -12.9% |
| R&D Expense | $13.0M | -42.5% |
| SG&A Expense | $479.0M | -12.4% |
| Operating Income | -$151.6M | -414.0% |
| Pre-tax Income | -$175.1M | -758.6% |
| Income Tax | -$28.5M | -258.2% |
| Net Income | -$146.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $186.9M | -27.0% |
| Short-term Investments | $11.1M | -5.5% |
| Accounts Receivable | $50.8M | -30.3% |
| Inventory | $190.2M | -32.1% |
| Current Assets | $538.6M | -23.3% |
| Total Assets | $1.47B | -18.7% |
| Current Liabilities | $296.6M | -9.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $111.7M | -5.8% |
| Capital Expenditures | $41.6M | -28.9% |
| Investing Cash Flow | -$38.0M | +71.8% |
| Financing Cash Flow | -$133.2M | -1341.2% |
| Free Cash Flow | $70.2M | +16.6% |
| -1805.6% |
| EPS (Basic) | -$2.95 | -1835.3% |
| EPS (Diluted) | -$2.95 | -1835.3% |
| Long-term Debt |
| $363.6M |
| -23.9% |
| Total Liabilities | $817.5M | -17.0% |
| Stockholders' Equity | $651.5M | -20.7% |